Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/21/2000WO2000077225A1 A novel insulin signaling molecule
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077211A1 Pyrexia-associated genes and pyrexia-associated proteins of plant
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077201A1 Livin; inhibitor-of-apoptosis protein-3 (iap-3)
12/21/2000WO2000077200A1 Receptor interacting protein rip3
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077195A1 Nucleic acid encoding novel egf-like growth factors
12/21/2000WO2000077192A1 Reg-binding protein
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077178A1 IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077166A2 Gene expression modulated in gastrointestinal inflammation
12/21/2000WO2000077047A1 Dog gonadotropin releasing hormone receptor
12/21/2000WO2000077046A1 A male-specific protein homologue involved in histocompatability
12/21/2000WO2000077045A1 Novel protein and dna thereof
12/21/2000WO2000077044A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/21/2000WO2000077043A2 Dna vaccines for pets and sport animals
12/21/2000WO2000077042A2 Parathyroid hormone receptor ligands
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077038A2 P202 is a tumor suppressor
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000077034A2 Amino acids from fish and soy proteins improve insulin sensitivity
12/21/2000WO2000077033A1 Retro-inverso peptides derived from interleukin-6
12/21/2000WO2000077031A2 Muc1 ligands
12/21/2000WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000WO2000077029A1 Retro-inverso peptides derived from leukemia inhibitory factor
12/21/2000WO2000077028A1 Retro-inverso peptides derived from interleukin-3
12/21/2000WO2000077026A1 49 human secreted proteins
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076985A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites
12/21/2000WO2000076554A1 Ligand-conjugated oligomeric compounds
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076544A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000WO2000076539A2 A method to improve protective immunity induced by polynucleotide vaccines
12/21/2000WO2000076536A1 Use of adenosine to minimize reperfusion injury
12/21/2000WO2000076535A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/21/2000WO2000076533A1 Hemoactive compositions and methods for their manufacture and use
12/21/2000WO2000076532A1 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076456A2 Modulators of fibrosis
12/21/2000WO2000076455A2 Chicken growth hormone releasing hormone receptor
12/21/2000WO2000076454A2 Therapeutic compositions for ophthalmic use and therapeutic compositions for brain central lesions
12/21/2000WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000WO2000076437A1 Soluble keratin peptide
12/21/2000WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053761A3 Human cytokine as ligand of the zalpha receptor and uses thereof
12/21/2000WO2000053752A3 Promotion or inhibition of angiogenesis and cardiovascularization
12/21/2000WO2000052167A8 Angiopoietin-related protein and nucleic acids
12/21/2000WO2000052056A3 Anti-plasmodium compositions and methods of use
12/21/2000WO2000052049A3 A method for purifying human growth hormone
12/21/2000WO2000051647A3 Animal model of allergies
12/21/2000WO2000050443A3 Secreted proteins and uses thereof
12/21/2000WO2000050442A3 Secreted proteins and uses thereof
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000048622A3 Method for inhibiting inflammatory responses
12/21/2000WO2000048621A3 Methods and compositions for regulating protein-protein interactions
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045834A3 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use
12/21/2000WO2000044366A3 Therapeutic compositions containing glutathione analogs
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000WO1998021230A8 Cyclic peptides that bind to urokinase-type plasminogen activator receptor
12/21/2000DE19928021A1 New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
12/21/2000DE19927764A1 New surfactant protein C ester, useful in compositions for treating adult or infant respiratory distress, has improved stability and activity
12/21/2000DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/21/2000DE19926041A1 Removing or separating viruses from potentially virus-containing samples using gel permeation chromatography on hydrophilic supports
12/21/2000DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin
12/21/2000CA2392514A1 Reg-binding protein
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2383041A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2378745A1 Ligand-conjugated oligomeric compounds
12/21/2000CA2376970A1 Thermogenesis-associated genes and thermogenesis-associated proteins of plant
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells